Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement

Lisa Billecke, PhD, Eva Maria Murga Penas, PhD, Annette May, PhD, Monika Engelhardt, Arnon Nagler, M.D., Merav Leiba, PhD, Nicolaus Kröger, PhD, Jozef Zustin, PhD, Andreas Marx, PhD, Jakob Matschke, Markus Tiemann, MD, Eray Gökkurt, Carsten Bokemeyer, MD, Georgia Schilling, PhD

Blood (2010) 116 (21): 4993.

https://doi.org/10.1182/blood.V116.21.4993.4993

Published: 2010

Journal Articles

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations

Cora Hallas, PhD, Christoph Schulte, MD, Klaus Heidorn, PhD, Markus Tiemann, MD

Blood (2010) 116 (21): 4096.

https://doi.org/10.1182/blood.V116.21.4096.4096

Published: 2010

Journal Articles

Mtor and PI3K Inhibitors Block Myeloma Cell Growth in a Synergistic Manner.

Andreas Guenther, Renate Burger, Wolfram Klapper, Markus Tiemann, Frank Bakker, Katja Brocke-Heidrich, Friedemann Horn, Martin Gramatzki

Blood (2009) 114 (22): 1843.

https://doi.org/10.1182/blood.V114.22.1843.1843

Published: 2009

Journal Articles

Pattern of Relapse in Localized Gastric Lymphoma Registered within the Prospective German Multicenter Study GIT NHL 01/92.

Ruediger Liersch, Wolfgang E. Berdel, Normann A. Willich, Gabriele Reinartz, Markus Tiemann, Peter Koch

Blood (2007) 110 (11): 1355.

https://doi.org/10.1182/blood.V110.11.1355.1355

Published: 2007

Journal Articles

Inhibitors of mToR Mediate Anti-Myeloma Activity by Apoptosis through the Extrinsic Pathway.

Andreas Günther, MD, Markus Tiemann, M.D., Frank Bakker, Ph.D., Wolfgang Baum, Ph.D., Katja Brocke-Heidrich, Ph.D., Friedemann Horn, Ph.D., Renate Burger, Ph.D., Martin Gramatzki, M.D.

Blood (2006) 108 (11): 3428.

https://doi.org/10.1182/blood.V108.11.3428.3428

Published: 2006

Journal Articles

Cancer/Testis Antigen CT45 Is Frequently Expressed in Hodgkin’s Lymphoma and Associated with Nodular Sclerosis Subtype and Advanced Disease.

Alexander Claviez, MD, Christine Mauz-Körholz, MD, Hans-Jürgen Heidebrecht, PhD, Günther Schellong, MD, Dieter Körholz, MD, Wolfgang Dörffel, MD, Reza Parwaresch, MD, Markus Tiemann, MD

Blood (2006) 108 (11): 4591.

https://doi.org/10.1182/blood.V108.11.4591.4591

Published: 2006

Journal Articles

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma

Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, Benedikt Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba

Blood (2006) 107 (6): 2271–2278.

https://doi.org/10.1182/blood-2005-07-2845

Published: 2006

Journal Articles

Estrogen and Progesteron Receptor Status in Pediatric and Adolescent Patients with Hodgkin’s Lymphoma.

Alexander Claviez, MD, Heike Lüders, Wolfgang Dörffel, MD, Günther Schellong, MD, Markus Tiemann, MD

Blood (2005) 106 (11): 4648.

https://doi.org/10.1182/blood.V106.11.4648.4648

Published: 2005

Journal Articles

Quantitative Assessment of Molecular Remission Following Autologous Stem Cell Transplantation Predicts Long Term Remission in Mantle Cell Lymphoma.

Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba

Blood (2005) 106 (11): 3275.

https://doi.org/10.1182/blood.V106.11.3275.3275

Published: 2005

Journal Articles

Zoledronate Exerts Direct Antiproliferative and Apoptotic Effects on Human Myeloma Cells In Vitro and In Vivo .

Andreas Guenther, MD, Sharon Gordon, PhD, Frank Bakker, PhD, Renate Burger, PhD, Markus Tiemann, MD, Jonathan R. Green, MD, Michael Rogers, PhD, Martin Gramatzki, MD

Blood (2005) 106 (11): 3387.

https://doi.org/10.1182/blood.V106.11.3387.3387

Published: 2005

Journal Articles

Rituximab during Pregnancy: Serum Levels, B Cell Counts and Immunoglobulin Levels in Mother and Child.

Birte Friedrichs, MD, Markus Tiemann, MD, Michael K. Wenger, MD, Karl Verpoort, MD, Norbert Schmitz, MD

Blood (2005) 106 (11): 1508.

https://doi.org/10.1182/blood.V106.11.1508.1508

Published: 2005

Journal Articles

POEMS Syndrome: A Patient with an IgA lambda Plasma Cell Disease. Expression Levels of VEGF and bFGF Correlates with Clinical Course.

Carsten Schrader, MD, Markus Tiemann, MD, Ute Zirrgiebel, Andreas Guenther, MD, Dirk Janssen, MD, Michael Kneba, MD, Martin Gramatzki, MD

Blood (2005) 106 (11): 5516.

https://doi.org/10.1182/blood.V106.11.5516.5516

Published: 2005

Journal Articles

AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping

Christian Hoffmann, Markus Tiemann, Carsten Schrader, Dirk Janssen, Eva Wolf, Mathias Vierbuchen, Reza Parwaresch, Karen Ernestus, Andreas Plettenberg, Albrecht Stoehr, Gerd Fatkenheuer, Christoph Wyen, Mark Oette, Heinz-August Horst

Blood (2005) 106 (5): 1762–1769.

https://doi.org/10.1182/blood-2004-12-4631

Published: 2005

Journal Articles

Immunohistochemical Detection of CD95L (Fas Ligand) in Mantle Cell Lymphoma: A Prognostic Factor for Clinical Outcome.

Carsten Schrader, M.D., Peter Meusers, M.D., Guenter Brittinger, M.D., Dirk Janssen, M.D., Reza Parwaresch, M.D., Michael Kneba, M.D., Markus Tiemann, M.D.

Blood (2004) 104 (11): 4566.

https://doi.org/10.1182/blood.V104.11.4566.4566

Published: 2004

Journal Articles

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

Markus Tiemann, MD, Alexander Claviez, MD, Heike Lueders, Martin Zimmermann, Guenther Schellong, MD, Wolfgang Doerffel, MD, Reza Parwaresch, MD

Blood (2004) 104 (11): 3118.

https://doi.org/10.1182/blood.V104.11.3118.3118

Published: 2004

Journal Articles

The Impact of Latent Epstein-Barr Virus Infection on Outcome in Children and Adolescents with Hodgkin’s Lymphoma.

Alexander Claviez, MD, Markus Tiemann, MD, Heike Lueders, Reza Parwaresch, MD, Guenther Schellong, MD, Wolfgang Doerffel, MD

Blood (2004) 104 (11): 3121.

https://doi.org/10.1182/blood.V104.11.3121.3121

Published: 2004

Journal Articles

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Kathrin Seidemann, Markus Tiemann, Martin Schrappe, Elif Yakisan, Ingrid Simonitsch, Gritta Janka-Schaub, Wolfgang Dörffel, Martin Zimmermann, Georg Mann, Helmut Gadner, Reza Parwaresch, Hansjörg Riehm, Alfred Reiter

Blood (2001) 97 (12): 3699–3706.

https://doi.org/10.1182/blood.V97.12.3699

Published: 2001

Journal Articles

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Alfred Reiter, Martin Schrappe, Wolf-Dieter Ludwig, Markus Tiemann, Reza Parwaresch, Martin Zimmermann, Eckard Schirg, Günter Henze, Günther Schellong, Helmut Gadner, Hansjörg Riehm

Blood (2000) 95 (2): 416–421.

https://doi.org/10.1182/blood.V95.2.416

Published: 2000

Journal Articles

Complex Variant Translocation t(1;2) With TPM3-ALK Fusion Due to Cryptic ALK Gene Rearrangement in Anaplastic Large-Cell Lymphoma

Reiner Siebert, Stefan Gesk, Lana Harder, Doris Steinemann, Werner Grote, Brigitte Schlegelberger, Markus Tiemann, Iwona Wlodarska, Verena Schemmel

Blood (1999) 94 (10): 3614–3617.

https://doi.org/10.1182/blood.V94.10.3614.422a38e_3614_3617

Published: 1999

Journal Articles

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Alfred Reiter, Martin Schrappe, Markus Tiemann, Wolf-Dieter Ludwig, Elif Yakisan, Martin Zimmermann, Georg Mann, Andreas Chott, Wolfram Ebell, Thomas Klingebiel, Norbert Graf, Bernhard Kremens, Stefan Müller-Weihrich, Hans-Jürgen Plüss, Felix Zintl, Günter Henze, Hansjörg Riehm

Blood (1999) 94 (10): 3294–3306.

https://doi.org/10.1182/blood.V94.10.3294.422k12_3294_3306

Published: 1999

NARROW

Cig-FISH-Analysis of Extramedullary Myeloma Manifestations Shows Similar Incidence of Prognostic Genetic Aberrations Compared to Bone Manifestations or Soft Tissue Involvement

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations

Mtor and PI3K Inhibitors Block Myeloma Cell Growth in a Synergistic Manner.

Pattern of Relapse in Localized Gastric Lymphoma Registered within the Prospective German Multicenter Study GIT NHL 01/92.

Inhibitors of mToR Mediate Anti-Myeloma Activity by Apoptosis through the Extrinsic Pathway.

Cancer/Testis Antigen CT45 Is Frequently Expressed in Hodgkin’s Lymphoma and Associated with Nodular Sclerosis Subtype and Advanced Disease.

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma

Estrogen and Progesteron Receptor Status in Pediatric and Adolescent Patients with Hodgkin’s Lymphoma.

Quantitative Assessment of Molecular Remission Following Autologous Stem Cell Transplantation Predicts Long Term Remission in Mantle Cell Lymphoma.

Zoledronate Exerts Direct Antiproliferative and Apoptotic Effects on Human Myeloma Cells In Vitro and In Vivo .

Rituximab during Pregnancy: Serum Levels, B Cell Counts and Immunoglobulin Levels in Mother and Child.

POEMS Syndrome: A Patient with an IgA lambda Plasma Cell Disease. Expression Levels of VEGF and bFGF Correlates with Clinical Course.

AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping

Immunohistochemical Detection of CD95L (Fas Ligand) in Mantle Cell Lymphoma: A Prognostic Factor for Clinical Outcome.

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

The Impact of Latent Epstein-Barr Virus Infection on Outcome in Children and Adolescents with Hodgkin’s Lymphoma.

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Complex Variant Translocation t(1;2) With TPM3-ALK Fusion Due to Cryptic ALK Gene Rearrangement in Anaplastic Large-Cell Lymphoma

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only